BlackRock’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6M | Buy |
4,605,109
+782,767
| +20% | +$3.33M | ﹤0.01% | 2995 |
|
|
2025
Q1 | $14.4M | Buy |
3,822,342
+32,510
| +0.9% | +$122K | ﹤0.01% | 3088 |
|
|
2024
Q4 | $22.1M | Sell |
3,789,832
-57,639
| -1% | -$336K | ﹤0.01% | 2945 |
|
|
2024
Q3 | $45.9M | Sell |
3,847,471
-152,047
| -4% | -$1.82M | ﹤0.01% | 2482 |
|
|
2024
Q2 | $43.3M | Buy |
3,999,518
+782,964
| +24% | +$8.47M | ﹤0.01% | 2460 |
|
|
2024
Q1 | $36.4M | Sell |
3,216,554
-47,353
| -1% | -$536K | ﹤0.01% | 2585 |
|
|
2023
Q4 | $45.8M | Buy |
3,263,907
+1,021,018
| +46% | +$14.3M | ﹤0.01% | 2484 |
|
|
2023
Q3 | $27.7M | Sell |
2,242,889
-90,411
| -4% | -$1.12M | ﹤0.01% | 2707 |
|
|
2023
Q2 | $21.1M | Buy |
2,333,300
+1,337,123
| +134% | +$12.1M | ﹤0.01% | 2948 |
|
|
2023
Q1 | $3.46M | Sell |
996,177
-47,018
| -5% | -$163K | ﹤0.01% | 3722 |
|
|
2022
Q4 | $2.56M | Sell |
1,043,195
-258,731
| -20% | -$634K | ﹤0.01% | 3948 |
|
|
2022
Q3 | $3.59M | Sell |
1,301,926
-3,578
| -0.3% | -$9.87K | ﹤0.01% | 3825 |
|
|
2022
Q2 | $5.31M | Sell |
1,305,504
-1,247,445
| -49% | -$5.08M | ﹤0.01% | 3713 |
|
|
2022
Q1 | $10.9M | Buy |
2,552,949
+254,785
| +11% | +$1.09M | ﹤0.01% | 3459 |
|
|
2021
Q4 | $21.5M | Sell |
2,298,164
-41,811
| -2% | -$391K | ﹤0.01% | 3173 |
|
|
2021
Q3 | $64.5M | Buy |
2,339,975
+870,796
| +59% | +$24M | ﹤0.01% | 2466 |
|
|
2021
Q2 | $41.1M | Buy |
1,469,179
+16,159
| +1% | +$452K | ﹤0.01% | 2790 |
|
|
2021
Q1 | $48.2M | Buy |
1,453,020
+768,311
| +112% | +$25.5M | ﹤0.01% | 2600 |
|
|
2020
Q4 | $32.9M | Buy |
+684,709
| New | +$32.9M | ﹤0.01% | 2680 |
|